Verified Peptides

Semaglutide Research & Scientific Studies

Explore the latest peer-reviewed research and scientific studies

About Semaglutide

Semaglutide is a synthetic GLP-1 receptor agonist used in metabolic and endocrine research. Supplied as a lyophilized powder for laboratory investigations of incretin receptor pharmacology, glucose-regulatory signaling, and downstream pathway activity in controlled experimental systems. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99(HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.

Purity>95-99
Categorypeptide

Latest Research

Featured Study

Patient Perceptions of Ozempic (Semaglutide) for Weight Loss: Mixed Methods Analysis of Online Medication Reviews.

Armanious AJ et al.J Med Internet Res2026

Recent research on Semaglutide: Patient Perceptions of Ozempic (Semaglutide) for Weight Loss: Mixed Methods Analysis of Online Medication Reviews.

Read Full Study on PubMed
Featured Study

Proteomic effects of short-term liraglutide vs. placebo in a blinded crossover RCT: Implications for efficacy, safety, and comparison with semaglutide.

Stefanakis K et al.Metabolism2026

Recent research on Semaglutide: Proteomic effects of short-term liraglutide vs. placebo in a blinded crossover RCT: Implications for efficacy, safety, and comparison with semaglutide.

Read Full Study on PubMed

Additional Studies

Discontinuation of oral semaglutide due to adverse effects: a database study on Japanese individuals with type 2 diabetes.

Ishiguro M et al.Diabetol Int2026

Recent research on Semaglutide: Discontinuation of oral semaglutide due to adverse effects: a database study on Japanese individuals with type 2 diabetes.

Read on PubMed

Cardiovascular Disease and Diabetes: A New Challenge in the Treatment and Management.

Riccioni G et al.Int J Mol Sci2025

Recent research on Semaglutide: Cardiovascular Disease and Diabetes: A New Challenge in the Treatment and Management.

Read on PubMed

GLP-1R Agonism Directly Improves the Pumping Capacity of Murine Collecting Lymphatic Vessels.

Schulz ME et al.bioRxiv2025

Recent research on Semaglutide: GLP-1R Agonism Directly Improves the Pumping Capacity of Murine Collecting Lymphatic Vessels.

Read on PubMed

Prescribing Patterns and Adverse Effects of Semaglutide: A Real-World Comparative Evaluation.

Whorton A et al.Healthcare (Basel)2025

Recent research on Semaglutide: Prescribing Patterns and Adverse Effects of Semaglutide: A Real-World Comparative Evaluation.

Read on PubMed

GLP-1 receptor agonists: trend, necessity, or blessing?

Shoaib N et al.Am J Manag Care2025

Recent research on Semaglutide: GLP-1 receptor agonists: trend, necessity, or blessing?

Read on PubMed

Related Research

Purchase Semaglutide from Verified Peptides

High-purity research peptides with full analytical verification

  • 99% Purity (HPLC Verified)
  • Full Certificate of Analysis
  • Same Day Dispatch
  • Free UK Shipping Over £75
Buy Semaglutide - 99% Purity, Same Day Dispatch

Research Disclaimer

The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.